kuo ming yeh - Infectious Diseases

Author Information

Kuo-Ming Yeh is a researcher affiliated with the Division of Infectious Diseases and Tropical Medicine at the Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center in Taipei, Taiwan. His work is primarily focused on infectious diseases, with a particular emphasis on the study and surveillance of the SARS-CoV-2 virus and its variants.

Research Contributions

Dr. Kuo-Ming Yeh has made significant contributions to the field of infectious diseases, especially during the COVID-19 pandemic. His research includes the development of novel diagnostic assays for rapid detection and surveillance of SARS-CoV-2 variants. He has also been involved in genomic analyses to understand the transmissibility of different SARS-CoV-2 strains and the evaluation of various testing methods for COVID-19 detection. His work is instrumental in enhancing the understanding and management of COVID-19, particularly in Taiwan.

Aliases

Throughout his academic and research career, Dr. Kuo-Ming Yeh has been referenced by various aliases, including Kuo Ming Yeh, Kuo-ming Yeh, and Kuoming Yeh.

Publication and Citation Metrics

Metric	Value
Total Citation Count	3435
h-index	30
Total Paper Count	91

Publications:

Clinical Characteristics of COVID-19 Patients and Application to an Artificial Intelligence System for Disease Surveillance

DOI: 10.3390/jcm11051437

Year: 2022

Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance

DOI: 10.1128/spectrum.02513-21

Year: 2022

Genomic analysis of early transmissibility assessment of the D614G mutant strain of SARS-CoV-2 in travelers returning to Taiwan from the United States of America

DOI: 10.7717/peerj.11991

Year: 2021

Clinical assessment of SARS-CoV-2 antigen rapid detection compared with RT-PCR assay for emerging variants at a high-throughput community testing site in Taiwan

DOI: 10.1016/j.ijid.2021.11.034

Year: 2021

Novel dual multiplex real-time RT-PCR assays for the rapid detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus using the BD MAX open system

DOI: 10.1080/22221751.2021.1873073

Year: 2021

Novel automated sample-to-result SARS-CoV-2 laboratory-developed RT-PCR assay for high-throughput testing using LabTurbo AIO 48 system

DOI: 10.1016/j.cca.2020.12.003

Year: 2021

Clinical Comparison of Three Sample-to-Answer Systems for Detecting SARS-CoV-2 in B.1.1.7 Lineage Emergence

DOI: 10.2147/IDR.S328327

Year: 2021

Multicenter study evaluating novel multi-specimen pooling assay for the detection of SARS-CoV-2: High sensitivity and high throughput testing

DOI: 10.1016/j.jmii.2021.08.003

Year: 2021

SARS-CoV-2 variants with T135I nucleocapsid mutations may affect antigen test performance

DOI: 10.1016/j.ijid.2021.11.006

Year: 2021

Investigation of One Familial Cluster of COVID-19 in Taiwan: Differentiation of Genetic Variation Among Isolates and Implications for Epidemiological Investigation and Surveillance by Genomic Assay

DOI: 10.2147/IDR.S298451

Year: 2021

What Does Asymptomatic Mean?

Why Is Aedes Aegypti So Efficient at Spreading Diseases?

What Are Some Common Diseases Spread by Direct Contact?

How is Dengue Transmitted?

What are the Limitations of PCR Tests?

When are Imaging Studies Recommended?

What Role Do Healthcare Professionals Play?

How Are Cases and Controls Selected?

What is the Public Health Impact of Chlamydia?

What Future Directions is the NIH Taking in Infectious Disease Research?

Partnered Content Networks

Relevant Topics